Shown below are the details for the item you selected from the list.
| File Name |
CMS-1325-P |
| Subject |
Medicare Part B - Competitive Acquisition of Outpatient Drugs and Biologicals |
| Publication/Implementation Date |
03/04/2005 |
| Quarterly Release Date |
01/01/2005 |
| Provider Type |
Physicians |
| Type of Regulation |
N/A |
| Regulation Summary |
This proposed rule would implement provisions of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 that require the implementation of a competitive acquisition program for certain Medicare Part B drugs not paid on a cost or prospective payment system basis. Beginning January 1, 2006, physicians will generally be given a choice between obtaining these drugs from vendors selected through a competitive bidding process or directly purchasing these drugs and being paid under the average sales price system. We are seeking comments on which of the proposed approaches we should use to implement the competitive acquisition program as well as the criteria and standards that should be applied in the selection and enrollment of vendors. |
| Additional Information |
N/A |
| | Downloads |
CMS-1325-P [PDF, 245KB] | | Related Links Inside CMS |
There are no Related Links Inside CMS
| | Related Links Outside CMS |  |
There are no Related Links Outside CMS
|
|
Last Modified Date : 10/03/2005
Help with File Formats and Plug-Ins
Email
Print